Nathan Segall works in the field of Allergy & Immunology. He researched medicine at University of Alabama School of Medicine. University of Alabama School of Medicine is ranked 37/17 in Research/PrimaryCare. He received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Super Doctor" and "Top MD". Dr. Nathan Segall has written publications. He has 6 publications published with PubMed. The lastest paper is: 'Effect of intranasal triamcinolone acetonide on basal hypothalamic-pituitary-adrenal axis function in children with allergic rhinitis.' He accepts Medicare payments and is listed with Medicare.gov.
NPI NUMBER | 1619982444 | |
NPPES Provider LastName | SEGALL | |
NPPES Provider FirstName | NATHAN | |
NPPES Provider ZIPCode | 303421626 | |
NPPES Provider State | GA | |
Specialty Description | Allergy/Immunology | |
Total Claim Count | 619.0 | |
Distinct Opioid Count | 0.0 | |
Opioid Claim Count | 0.0 | |
Percent Opioid Claims | 0.0 |
National Provider Identifier [NPI] | 1619982444 |
Last Name Of The Provider | SEGALL |
First Name Of The Provider | NATHAN |
View All |
Dr. Rayasam Prasad, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Elizabeth E. Marquetti IV, MD |